Concepedia

Safety and Immunogenicity of the BNT162b2 mRNA COVID-19 Vaccine in Patients after Allogeneic HCT or CD19-based CART therapy—A Single-Center Prospective Cohort Study

Ron Ram, David Hagin, Nino Kikozashvilli, Tal Freund, Odelia Amit, Yael Bar‐On, Ofrat Beyar‐Katz, Gabi Shefer, M. Morales, Chen Karni,

Transplantation and Cellular Therapy · 2021 · 159 citations · 15 references

DOIFull text

Open access

References

15

Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine

Fernando P. Polack, Stephen J. Thomas, Nicholas Kitchin et al. · New England Journal of Medicine · 2020 · 15.1K citations · Full text

COVID-19 vaccine BNT162b1 elicits human antibody and TH1 T cell responses

Uğur Şahin, Alexander Muik, Evelyna Derhovanessian et al. · Nature · 2020 · 2K citations · Full text

, , +7

Safety and Immunogenicity of SARS-CoV-2 mRNA-1273 Vaccine in Older Adults

Evan J. Anderson, Nadine Rouphael, Alicia T. Widge et al. · New England Journal of Medicine · 2020 · 1.6K citations · Full text

EBMT−NIH−CIBMTR Task Force position statement on standardized terminology & guidance for graft-versus-host disease assessment

Hélène Schoemans, Stephanie J. Lee, James L.M. Ferrara et al. · Bone Marrow Transplantation · 2018 · 460 citations · Full text

Thrombocytopenia following Pfizer and Moderna <scp>SARS‐CoV</scp>‐2 vaccination

Eun‐Ju Lee, Douglas B. Cines, Terry Gernsheimer et al. · American Journal of Hematology · 2021 · 383 citations · Full text